No Picture
News

Qpex Biopharma and Brii Biosciences Enter Into a Strategic Collaboration to Develop and Commercialize Antibiotics for Drug-Resistant Infections in China

— Multi-product collaboration will address pathogens for which the World Health Organization (WHO) has declared there is a “critical need” for new drugs due to carbapenem-resistance in Acinetobacter, Pseudomonas aeruginosa, and Enterobacteriaceae (CRE… […]

No Picture
News

Prometheus Biosciences, Inc., Enters Into Multi-Target Strategic Collaboration with Takeda to Develop Targeted Therapies for Inflammatory Bowel Disease

Agreement Leverages Prometheus Biosciences’ Proprietary Bioinformatics Analysis Platform, Companion Diagnostics to Speed Development and Discovery

SAN DIEGO, Oct. 3, 2019 /PRNewswire/ — Prometheus Biosciences, Inc., a biopharmaceutical company commi… […]

No Picture
News

Amplyx Pharmaceuticals Licenses Phase 2 Drug Candidate for BK Viral Disease in Transplant Patients

Company expands pipeline of innovative therapies for immunocompromised patients

SAN DIEGO, Sept. 16, 2019 /PRNewswire/ — Amplyx Pharmaceuticals, a biotech company dedicated to developing innovative therapies for debilitating and life-threatening dis… […]

No Picture
News

Ionis licenses hepatitis B program to GSK

– GSK exercises option to license program following positive Phase 2 results- Transaction provides Ionis with significant participation in the commercial success of HBV program

CARLSBAD, Calif., Aug. 27, 2019 /PRNewswire/ — Ionis Pharmaceuticals, In… […]

No Picture
News

MiLaboratories And MIODx Collaborate On Services And Product Development In TCR And BCR Repertoire Profiling

SAN DIEGO and SAN JOSE, Calif., Aug. 14, 2019 /PRNewswire/ — MiLaboratories LLC, a technology leader in T-cell receptor (TCR) and B-cell receptor (BCR) profiling and MIODx, a well-known immunosequencing specialist, announced today a collaboration a… […]

No Picture
News

Medical Marijuana, Inc. Subsidiary Kannaway® Enters Strategic Partnership With Endocanna Health to Create and Sell Endocannabinoid DNA Test Products

SAN DIEGO, Aug. 1, 2019 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first publicly traded cannabis company in the United States that launched the world’s preeminent cannabis-derived nutraceutical products, brands and su… […]

No Picture
News

Mirati Announces Clinical Collaboration to Evaluate MRTX849 in Combination with SHP2 Inhibitor TNO155

SAN DIEGO, July 9, 2019 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced a clinical collaboration agreement with Novartis to evaluate the combination of MRTX849, Mirati’s investiga… […]

No Picture
News

OncoSec Receives Exclusive Licensing Rights from Dana-Farber Cancer Institute to CAR T-Cell Therapies for the Treatment of Solid Tumor Cancers

Development Collaboration Will Initially Focus on CAR T-Cell Therapy for Triple-Negative Breast Cancer

SAN DIEGO and PENNINGTON, N.J., June 27, 2019 /PRNewswire/ — OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing late-stage… […]

No Picture
News

NYU Winthrop and Progenity Collaborate to Develop Diagnostic Test to Assess Risk for Preterm Birth

MINEOLA, N.Y. and SAN DIEGO, June 25, 2019 /PRNewswire/ — NYU Winthrop Hospital and Progenity, Inc., today announced a collaborative research and development initiative for women’s health with a focus on preterm births. As part of the init… […]